Dennis Brooks

1.1k total citations · 1 hit paper
14 papers, 563 citations indexed

About

Dennis Brooks is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Dennis Brooks has authored 14 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Infectious Diseases and 4 papers in Health. Recurrent topics in Dennis Brooks's work include Vaccine Coverage and Hesitancy (4 papers), Viral gastroenteritis research and epidemiology (3 papers) and Respiratory viral infections research (3 papers). Dennis Brooks is often cited by papers focused on Vaccine Coverage and Hesitancy (4 papers), Viral gastroenteritis research and epidemiology (3 papers) and Respiratory viral infections research (3 papers). Dennis Brooks collaborates with scholars based in United States, United Kingdom and Sweden. Dennis Brooks's co-authors include Jeffrey L. Cleland, Richard C. Wasserman, Paul M. Darden, Chung C. Hsu, Alison B. Bocian, Eileen Duenas, Ben J. Boyd, Janet G. Yang, Herman Chu and Andrew J. S. Jones and has published in prestigious journals such as Circulation, Biomaterials and PEDIATRICS.

In The Last Decade

Dennis Brooks

14 papers receiving 546 citations

Hit Papers

Efficacy and safety of intramuscular administration of ti... 2022 2026 2023 2024 2022 40 80 120

Peers

Dennis Brooks
Dennis Brooks
Citations per year, relative to Dennis Brooks Dennis Brooks (= 1×) peers Anjali Pandya

Countries citing papers authored by Dennis Brooks

Since Specialization
Citations

This map shows the geographic impact of Dennis Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dennis Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dennis Brooks more than expected).

Fields of papers citing papers by Dennis Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dennis Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dennis Brooks. The network helps show where Dennis Brooks may publish in the future.

Co-authorship network of co-authors of Dennis Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Dennis Brooks. A scholar is included among the top collaborators of Dennis Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dennis Brooks. Dennis Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mäki-Petäjä, Kaisa, Stefano Bartesaghi, Andrea L. Vavere, et al.. (2024). Abstract 4137311: Inhibition of IL-33 by tozorakimab in patients with diabetic kidney disease: Cardiovascular insights from FRONTIER-1. Circulation. 150(Suppl_1). 1 indexed citations
2.
Albayaty, Muna, Dennis Brooks, Rosalinda H. Arends, et al.. (2023). Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab) in Healthy Adults. The Journal of Infectious Diseases. 227(10). 1153–1163. 11 indexed citations
3.
Montgomery, Hugh, Richard Hobbs, Francisco Padilla, et al.. (2022). Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine. 10(10). 985–996. 127 indexed citations breakdown →
4.
Hammitt, Laura L., Ron Dagan, Yuan Yuan, et al.. (2021). LB13. The Efficacy and Impact in Heathy Infants of Nirsevimab on Medically Attended RSV Lower Respiratory Tract Infection. Open Forum Infectious Diseases. 8(Supplement_1). S811–S812. 2 indexed citations
5.
Lin, Tzou‐Yien, et al.. (2010). Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine. 28(48). 7589–7605. 35 indexed citations
6.
Darden, Paul M., James A. Taylor, Dennis Brooks, et al.. (2007). How Should Immunization Rates Be Measured in the Office Setting? A Study from PROS and NMA PedsNet. Clinical Pediatrics. 47(3). 252–260. 2 indexed citations
7.
Okumu, Franklin W., et al.. (2002). Sustained delivery of human growth hormone from a novel gel system: SABERTM. Biomaterials. 23(22). 4353–4358. 54 indexed citations
11.
Cleland, Jeffrey L., Ben J. Boyd, Janet G. Yang, et al.. (1997). The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres. Pharmaceutical Research. 14(4). 420–425. 87 indexed citations
12.
Overcashier, David E., Dennis Brooks, Henry R. Costantino, & Chung C. Hsu. (1997). Preparation of Excipient-Free Recombinant Human Tissue-Type Plasminogen Activator by Lyophilization from Ammonium Bicarbonate Solution: An Investigation of the Two-Stage Sublimation Phenomenon. Journal of Pharmaceutical Sciences. 86(4). 455–459. 12 indexed citations
13.
Cleland, Jeffrey L., Eileen Duenas, Ann L. Daugherty, et al.. (1997). Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. Journal of Controlled Release. 49(2-3). 193–205. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026